Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
| ▸ | RXRG | P48443 | 1/20 | 0.42 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL889672 | 0.90 | RXRA (0.43) | RXRARXRBRXRGAVPR1AALDH1A1 | |
| SCHEMBL12349719 | 0.85 | ESR1 (0.41) | RXRARXRBRXRGALDH1A1MAPT | |
| SCHEMBL8281404 | 0.83 | S1PR1 (0.47) | ALDH1A1MAPTSMN1; SMN2HPGDKDM4E | |
| SCHEMBL889806 | 0.82 | AVPR1A (0.44) | AVPR1AALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL889730 | 0.82 | AVPR1A (0.46) | AVPR1AALDH1A1SMN1; SMN2HPGDOPRD1 | |
| SCHEMBL889741 | 0.82 | AVPR1A (0.46) | AVPR1AALDH1A1SMN1; SMN2HPGDOPRD1 | |
| SCHEMBL889656 | 0.81 | AVPR1A (0.42) | AVPR1AALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL889696 | 0.81 | RXRA (0.46) | RXRARXRBRXRGAVPR1AALDH1A1 | |
| SCHEMBL889752 | 0.81 | AVPR1A (0.45) | AVPR1AALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL889871 | 0.80 | AVPR1A (0.44) | AVPR1AALDH1A1SMN1; SMN2HPGDOPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9806268-B2 | Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-9806268-B2 | Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-20160285005-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20160285005-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-09-29 | — | — | US | disclosed |
| US-9359335-B2 | Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-06-07 | — | — | US | disclosed |
| US-9359335-B2 | Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-06-07 | — | — | US | disclosed |
| US-20150197508-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-07-16 | — | — | US | disclosed |
| US-20150197508-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-07-16 | — | — | US | disclosed |
| US-8993125-B2 | Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-03-31 | — | — | US | disclosed |
| US-20110285276-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150197508-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | DRD3, DRD1, GRK1 | RXRA 858/4885RXRB 928/4885RXRG 915/4885 |
| US-20110285276-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | DRD3, DRD1, CYP1A1 | RXRA 928/4885RXRB 994/4885RXRG 937/4885 |
| US-20160285005-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | DRD3, DRD1, GRK1 | RXRA 858/4885RXRB 928/4885RXRG 915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.